share_log

HealthEquity, Inc. (NASDAQ:HQY) Sees Significant Decline in Short Interest

HealthEquity, Inc. (NASDAQ:HQY) Sees Significant Decline in Short Interest

健康股权公司(纳斯达克股票代码:HQY)看到空头股数股价大幅下降
Defense World ·  2022/09/20 04:51

HealthEquity, Inc. (NASDAQ:HQY – Get Rating) was the target of a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 3,620,000 shares, a decrease of 7.7% from the August 15th total of 3,920,000 shares. Based on an average trading volume of 765,800 shares, the days-to-cover ratio is currently 4.7 days. Approximately 4.4% of the company's stock are sold short.

健康股权公司(纳斯达克代码:HQY-GET Rating)是空头股数8月份大幅下跌的目标。截至8月31日,空头股数共有3,620,000股,较8月15日的3,920,000股减少7.7%。以平均成交量76.58万股计算,目前天数与回补比率为4.7天。该公司约4.4%的股票被卖空。

HealthEquity Trading Up 0.7 %

HealthEquity交易上涨0.7%

HealthEquity stock opened at $71.88 on Tuesday. HealthEquity has a twelve month low of $36.81 and a twelve month high of $73.29. The stock has a 50 day moving average of $62.21 and a two-hundred day moving average of $62.51. The stock has a market capitalization of $6.08 billion, a price-to-earnings ratio of -97.14, a PEG ratio of 4.25 and a beta of 0.90.

HealthEquity股票周二开盘报71.88美元。HealthEquity的12个月低点为36.81美元,12个月高位为73.29美元。该股的50日移动均线切入位为62.21美元,200日移动均线切入位为62.51美元。该股市值为60.8亿美元,市盈率为-97.14倍,市盈率为4.25倍,贝塔系数为0.90。

Get
到达
HealthEquity
健康权益
alerts:
警报:

HealthEquity (NASDAQ:HQY – Get Rating) last posted its quarterly earnings data on Tuesday, September 6th. The company reported $0.33 earnings per share for the quarter, hitting analysts' consensus estimates of $0.33. HealthEquity had a positive return on equity of 2.86% and a negative net margin of 7.82%. During the same quarter in the previous year, the business posted $0.21 earnings per share. Equities analysts predict that HealthEquity will post 0.69 earnings per share for the current year.

健康股票(纳斯达克代码:HQY-GET Rating)最近一次公布季度收益数据是在9月6日(星期二)。该公司公布本季度每股收益为0.33美元,超过了分析师普遍预期的0.33美元。HealthEquity的股本回报率为正2.86%,净利润率为负7.82%。在去年同一季度,该业务公布的每股收益为0.21美元。股票分析师预测,HealthEquity本年度每股收益将为0.69美元。

Insider Activity

内幕活动

In other news, COO Edward Bloomberg sold 1,000 shares of the stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $57.63, for a total value of $57,630.00. Following the transaction, the chief operating officer now owns 59,850 shares in the company, valued at approximately $3,449,155.50. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 2.80% of the company's stock.
在其他新闻方面,首席运营官爱德华·布隆伯格在8月1日星期一的交易中出售了1,000股该公司股票。这只股票的平均售价为57.63美元,总价值为57630.00美元。交易完成后,首席运营官现在拥有该公司59,850股股票,价值约3,449,155.50美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,可以通过这个超级链接获得。公司内部人士持有该公司2.80%的股份。

Institutional Trading of HealthEquity

医疗股权的机构交易

Hedge funds have recently modified their holdings of the business. Private Trust Co. NA acquired a new stake in shares of HealthEquity in the 2nd quarter valued at approximately $28,000. Assetmark Inc. lifted its holdings in shares of HealthEquity by 387.1% in the 2nd quarter. Assetmark Inc. now owns 755 shares of the company's stock valued at $46,000 after buying an additional 600 shares during the period. Signaturefd LLC lifted its holdings in shares of HealthEquity by 44.3% in the 1st quarter. Signaturefd LLC now owns 954 shares of the company's stock valued at $64,000 after buying an additional 293 shares during the period. Clearstead Advisors LLC acquired a new stake in shares of HealthEquity in the 1st quarter valued at approximately $65,000. Finally, Eagle Bay Advisors LLC lifted its holdings in shares of HealthEquity by 137.8% in the 2nd quarter. Eagle Bay Advisors LLC now owns 1,108 shares of the company's stock valued at $68,000 after buying an additional 642 shares during the period. 99.43% of the stock is owned by institutional investors and hedge funds.

对冲基金最近调整了对该业务的持股。私人信托公司NA在第二季度收购了HealthEquity的新股份,价值约2.8万美元。AssetMark Inc.在第二季度增持了HealthEquity的股票,增幅为387.1%。AssetMark Inc.现在持有该公司755股股票,价值46,000美元,在此期间又购买了600股。Signaturefd LLC在第一季度增持了44.3%的HealthEquity股票。Signaturefd LLC在此期间又购买了293股,现在拥有954股该公司股票,价值6.4万美元。Clearstead Advisors LLC在第一季度收购了HealthEquity的新股份,价值约6.5万美元。最后,Eagle Bay Advisors LLC在第二季度增持了137.8%的HealthEquity股票。Eagle Bay Advisors LLC现在拥有1,108股该公司的股票,价值6.8万美元,在此期间又购买了642股。99.43%的股票由机构投资者和对冲基金持有。

Wall Street Analyst Weigh In

华尔街分析师也加入进来

A number of research analysts have recently commented on the company. SVB Leerink increased their price objective on HealthEquity from $67.00 to $76.00 and gave the company an "outperform" rating in a report on Tuesday, June 7th. The Goldman Sachs Group assumed coverage on HealthEquity in a research note on Tuesday, July 12th. They set a "sell" rating and a $59.00 price target on the stock. Wells Fargo & Company raised their price target on HealthEquity from $95.00 to $100.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 13th. Barrington Research raised their price target on HealthEquity from $70.00 to $75.00 in a research note on Tuesday, June 7th. Finally, Robert W. Baird raised their price target on HealthEquity from $47.00 to $67.00 and gave the stock a "neutral" rating in a research note on Wednesday, September 7th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $75.36.

一些研究分析师最近对该公司发表了评论。SVB Leerink在6月7日(星期二)的一份报告中将HealthEquity的目标价从67.00美元上调至76.00美元,并给予该公司“跑赢大盘”的评级。7月12日,星期二,高盛在一份研究报告中对HealthEquity进行了报道。他们为该股设定了“卖出”评级和59.00美元的目标价。富国银行将HealthEquity的目标价从95美元上调至100.00美元,并在9月13日(星期二)的一份研究报告中给予该股“增持”评级。巴灵顿研究公司在6月7日星期二的一份研究报告中将HealthEquity的目标价从70.00美元上调至75.00美元。最后,罗伯特·W·贝尔德在9月7日星期三的一份研究报告中将HealthEquity的目标价从47.00美元上调至67.00美元,并给予该股“中性”评级。两名股票研究分析师对该股的评级为卖出,一名分析师给予该公司持有评级,十一名分析师给予该公司买入评级。根据MarketBeat.com,该公司目前的平均评级为“中等买入”,平均目标价为75.36美元.

About HealthEquity

关于HealthEquity

(Get Rating)

(获取评级)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

HealthEquity,Inc.为美国的消费者和雇主提供技术支持的服务平台。该公司提供基于云的平台,供个人做出健康储蓄和支出决定、支付医疗账单、比较治疗方案和价格、接收个性化福利和临床信息、赚取健康激励、增加储蓄并做出投资选择;以及健康储蓄账户。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on HealthEquity (HQY)
  • Oracle's Short-Term Pain Could Be Your Long-Term Gain
  • Lucid is Looking Like a Clear EV Winner
  • Still Lovin' It: Investors Keep Visiting McDonald's
  • Did FedEx Just Deliver A Buying Opportunity?
  • Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
  • 免费获取StockNews.com关于HealthEquity(HQY)的研究报告
  • 甲骨文的短期痛苦可能是你的长期收益
  • Lucid看起来像是电动汽车的赢家
  • 仍然爱着它:投资者继续光顾麦当劳
  • 联邦快递刚刚提供了一个买入机会吗?
  • 自动区重新进入拉力赛模式,新高在望

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.

接受HealthEquity Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对HealthEquity和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发